Health Catalyst, Inc.HCAT
Health Care · Health Care Equipment & Services · NASDAQ · United States
Health Catalyst, Inc. is a healthcare intelligence company designed to accelerate measurable improvement for health systems across cost, clinical, and consumer performance. Backed by deep domain expertise, proprietary AI-driven technology, and $2.8 billion in documented outcomes, it helps health systems move from data to confident, measurable action.
Key ratios
Operating cash flow growth
314.7%TTM
2025
-95.0%
FCF / Sales
-0.1%2025
2024
4.2%2023
-11.6%
Net margin
-90.6%TTM
2025
-57.2%2024
-22.7%2023
-39.9%
ROA
-4.0%2025
2024
-4.6%2023
-8.0%
ROE
-58.3%2025
2024
-19.0%2023
-29.8%
Revenue growth
1.5%2025
2024
3.6%2023
7.1%
Recent news
Health Catalyst Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Health Catalyst Appoints Simeon Kohl as Chief Executive Officer and President
Health Catalyst to Participate in Upcoming Investor Conference
Track HCAT in your journal
Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.
Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer